Effect of Bio-electromagnetic Energy Regulation Therapy on Erectile Dysfunction in Patients With Multiple Sclerosis
NCT05615454 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2023-03-09
Summary
Multiple sclerosis (MS) is an inflammatory disease that affects the brain and spinal cord. There are potential impacts on neurological functions, including sensory and autonomic functions. The Primary observed in males with MS is erectile dysfunction (ED), which substantially impacts the quality of life. There is increasing literature on electromagnetic fields' biological and clinical effects, particularly on ED.
Conditions
- Erectile Dysfunction Due to Diseases Classified Elsewhere
- Multiple Sclerosis, Relapsing-Remitting
Interventions
- DEVICE
-
bio-electromagnetic energy regulation therapy (BEMER) machine model type: B.BOX CLASSIC, model NO: 420100, 12-15 Volt, (BEMER Int.AG, Liechtenstein product).
The experimental group (receive the BEMER therapy) for five sessions/week for three weeks. Plus, pelvic floor exercise.
- DEVICE
-
placebo BEMER
Comparison group (receive placebo BEMER therapy) for five sessions/week for three weeks. Plus, pelvic floor exercise.
Sponsors & Collaborators
-
Imam Abdulrahman Bin Faisal University
lead OTHER
Principal Investigators
-
Abdulaziz A Alzahrani, PhDcandidate · imam abdurhman bin faisal
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-28
- Primary Completion
- 2023-12-30
- Completion
- 2024-03-30
Countries
- Saudi Arabia
Study Locations
More Related Trials
-
Light Therapy as Treatment for Fatigue in Multiple Sclerosis
NCT03060759 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis
NCT01377870 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Understanding Magnetic Resonance Imaging in Multiple Sclerosis
NCT03872583 ·Status: COMPLETED ·Phase: NA
-
Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Sclerosis
NCT06401928 ·Status: COMPLETED ·Phase: NA
-
Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple Sclerosis
NCT01745783 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effect of a Series of Systemic Cryotherapy Treatments on the Functional State of Patients With Multiple Sclerosis
NCT04533971 ·Status: COMPLETED ·Phase: NA
-
Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple Sclerosis
NCT07235644 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Analyze the Effect of Acupuncture on Mobility And Quality of Life in Multiple Sclerosis
NCT03174379 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Impact of Lesions of the Motor and Proprioceptive Brain and Pan-medullary Pathways on Their Clinically and Electrophysiologically Assessed Function in Multiple Sclerosis
NCT04220814 ·Status: COMPLETED ·Phase: NA
-
Effect of Photobiomodulation Treatment in Individuals With Multiple Sclerosis:
NCT03360487 ·Status: UNKNOWN ·Phase: PHASE2
-
Telerehabilitation in Multiple Sclerosis
NCT04979845 ·Status: UNKNOWN ·Phase: NA
-
3D OPTIMIZED WMN MPRAGE Increased Detection of Focal Spinal Cord Lesion in Multiple Sclerosis (WHINUME)
NCT05227092 ·Status: RECRUITING ·Phase: NA
-
Photobiomodulation Therapy in Persons With Multiple Sclerosis
NCT03691766 ·Status: COMPLETED ·Phase: NA
-
Pathological Basis of MRI Signal Changes in Multiple Sclerosis
NCT02659956 ·Status: RECRUITING
-
Artificial Intelligence-Assisted Magnetic Resonance Imaging for Quality, Efficiency and Equity in the National Health Service (NHS) Care of Multiple Sclerosis
NCT07111637 ·Status: RECRUITING ·Phase: NA
-
Telephone-Delivered Exercise for Multiple Sclerosis Fatigue
NCT03256851 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Reproducibility of the Measurement of the QSM Signal (Quantitative Susceptibility Mapping)
NCT04465448 ·Status: TERMINATED
-
Complementary and Alternative Care in Multiple Sclerosis
NCT01703429 ·Status: RECRUITING
-
Effect of Resistance Training on Psychophysiological Indicators in People With Multiple Sclerosis
NCT07118514 ·Status: COMPLETED ·Phase: NA
-
Study of Social Cognition by Morphological and Functional Imaging in Multiple Sclerosis Patients
NCT02290587 ·Status: COMPLETED ·Phase: NA
-
Mesenchymal Stem Cells for Multiple Sclerosis
NCT01730547 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Function Magnetic Resonance Imaging to Assess Two Therapeutic Strategies in Multiple Sclerosis (NeuroRehEM).
NCT05270239 ·Status: COMPLETED ·Phase: NA
-
Motor Evoked Potentials as a Biomarker in Alemtuzumab Treated Multiple Sclerosis Patients
NCT02623946 ·Status: COMPLETED
-
An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)
NCT01838668 ·Status: COMPLETED ·Phase: PHASE3
-
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
NCT00001248 ·Status: RECRUITING